Last price paid | 3.29 | |
Change | +1.23% [ +0.04 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 11.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 20.03.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +235.20% |
Year to date (YTD) | +3.79% |
1 month | +10.40% |
3 months | -4.08% |
1 year | +167.48% |
3 years | n.a. |
Issue price | 0.98 |
Underlying price on issue | 769.90 |
Premium | 0.00% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1250718827 |
Symbol | IPGVFZ |
Security | 125071882 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Part Grp Hldg N, CH0024608827 |
Underlying ISIN | CH0024608827 |
Funding level | 571.938300 |
Stop-loss level | 593.852100 |
Distance to stop-loss level | 51.58% |
Long/Short type | Long |
Subscription ratio | 200.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 16.03.2023 |
Premium | 0.19% |
Premium p.a. | n.a. |
Leverage | 1.87 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 654.561700 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
NOVARTIS N | 100.22 |
Alcon AG | 81.42 |
ROCHE GS | 253.50 |
UBS | 27.88 |
SWISSCOM N | 528.00 |
Name | Price |
---|---|
KUEHNE & NAGEL | 256.40 |
Swiss Life Hldg | 673.60 |
Givaudan | 4'343.00 |
LOGITECH INT. | 81.48 |
Lonza Group | 519.00 |